Table of Contents
1. Executive Summary
2. Market Overview
3. Global Pharmaceutical Outlook
4. Key Market Trends
5. Key Success Factors
6. Key Inclusions
7. Global Spending (in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
8. Market Background
9. Global Spending 2018 to 2022 and Forecast 2023 to 2033, by Solution Type
- 9.1. eCOA (Electronic Clinical Outcome Assessment)
- 9.1.1. ePROs (Patient Reported Outcomes)
- 9.1.2. ClinROs (Clinician Reported Outcomes)
- 9.1.3. ObsROs (Observer Reported Outcomes)
- 9.1.4. PerfOs (Performance Outcomes)
- 9.2. eSource
- 9.3. Clinical Trials Solutions
- 9.3.1. Clinical Data Management Systems (CDMS)
- 9.3.2. Clinical Trial Management Systems (CTMS)
- 9.3.3. Randomization and Trial Supply Management Systems (RTMS)
- 9.3.4. Trial Planning and Safety Solutions
- 9.4. Electronic Data Capture (EDC)
10. Global Spending Analysis 2018 to 2022 and Forecast 2023 to 2033, by Deployment
- 10.1. Licensed Enterprise (On Premise)
- 10.2. Cloud-based (SaaS)
11. Global Spending Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User
- 11.1. Contract Research Organizations
- 11.2. Hospitals & Other Healthcare Facilities
- 11.3. Pharmaceutical/Biotechnology/Medical Devices Companies
- 11.4. Educational & Research Institutes
12. Global Spending Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
- 12.1. North America
- 12.2. Latin America
- 12.3. Europe
- 12.4. Middle East and Africa (MEA)
- 12.5. East Asia
- 12.6. South Asia
- 12.7. Oceania
13. North America Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
14. Latin America Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
15. Europe Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
16. South Asia Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
17. East Asia Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
18. Oceania Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
19. Middle East and Africa Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
20. Emerging Countries Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
21. Market Structure Analysis
22. Competition Analysis
- 22.1. OpenClinica, LLC
- 22.2. CRF Health, Inc.
- 22.3. ERT Clinical
- 22.4. Medidata Solutions, Inc.
- 22.5. ArisGlobal LLC
- 22.6. Health Diary, Inc.
- 22.7. ICON plc
- 22.8. PAREXEL International Corporation
- 22.9. OmniComm Systems, Inc.
- 22.10. Medrio, Inc.
- 22.11. Medable
- 22.12. Oracle Corp
- 22.13. Medpace Holdings, Inc.
- 22.14. Covance, Inc.
- 22.15. Bio-Optronics, Inc.
23. Assumptions and Acronyms Used
24. Research Methodology
List of Tables
Table 01: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 02: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 03: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 04: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
Table 05: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 06: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 07: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 08: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 09: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 10: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 11: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 12: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 13: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 14: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 15: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 16: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 17: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 18: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 19: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 20: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 21: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 22: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 23: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 24: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 25: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 26: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 27: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 28: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 29: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 30: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 31: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 32: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 33: China Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 34: China Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 35: China Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 36: India Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 37: India Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 38: India Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 39: Brazil Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 40: Brazil Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 41: Brazil Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
List of Figures
Figure 01: Spending Share, 2023 & 2028
Figure 02: Number of FDA approved pharmaceuticals (2018 to 2022)
Figure 03: Global Spending Analysis (US$ Mn), 2018 to 2022
Figure 04: Global Spending Forecast (US$ Mn), 2023 to 2033
Figure 05: Spending (US$ Mn) Analysis, by eCOA segment, 2018 to 2022
Figure 06: Spending Y-o-Y Growth (%), by eCOA segment, 2022 to 2033
Figure 07: Spending (US$ Mn) Analysis, by eSource segment, 2018 to 2022
Figure 08: Software Spending Y-o-Y Growth (%), by eSource segment, 2022 to 2033
Figure 09: Spending (US$ Mn) Analysis, by segment, 2018 to 2022
Figure 10: Spending Y-o-Y Growth (%), by segment, 2022 to 2033
Figure 11: Spending (US$ Mn) Analysis, by EDC segment, 2018 to 2022
Figure 12: Software Spending Y-o-Y Growth (%), by EDC segment, 2022 to 2033
Figure 13: Spending (US$ Mn) Analysis, by Licensed Enterprise (On Premise) segment, 2018 to 2022
Figure 14: Spending Y-o-Y Growth (%), by Licensed Enterprise (On Premise) segment, 2022 to 2033
Figure 15: Spending (US$ Mn) Analysis, by Cloud Based (SaaS) segment, 2018 to 2022
Figure 16: Software Spending Y-o-Y Growth (%), by Cloud Based (SaaS) segment, 2022 to 2033
Figure 17: Spending (US$ Mn) Analysis, by Contract Research Organizations segment, 2018 to 2022
Figure 18: Spending Y-o-Y Growth (%), by Contract Research Organizations segment, 2022 to 2033
Figure 19: Spending (US$ Mn) Analysis, by Hospitals & Other Healthcare Facilities segment, 2018 to 2022
Figure 20: Software Spending Y-o-Y Growth (%), by Hospitals & Other Healthcare Facilities segment, 2022 to 2033
Figure 21: Spending (US$ Mn) Analysis, by Pharmaceutical/Biotechnology/Medical Device Companies segment, 2018 to 2022
Figure 22: Spending Y-o-Y Growth (%), by Pharmaceutical/Biotechnology/Medical Device Companies segment, 2022 to 2033
Figure 23: Spending (US$ Mn) Analysis, by Educational & Research Institutes segment, 2018 to 2022
Figure 24: Software Spending Y-o-Y Growth (%), by Educational & Research Institutes segment, 2022 to 2033
Figure 25: Global Market Attractiveness Analysis, By Solution Type
Figure 26: Global Market Attractiveness Analysis, By Deployment
Figure 27: Global Market Attractiveness Analysis, By End User
Figure 28: Global Market Attractiveness Analysis, By Region
Figure 29: North America spending share, by Solution Type (2022)
Figure 30: North America Spending, Snapshot
Figure 31: North America Spending (US$ Mn), 2018 to 2022
Figure 32: North America Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 33: North America Market Attractiveness Analysis, By Solution Type
Figure 34: North America Market Attractiveness Analysis, By Deployment
Figure 35: North America Market Attractiveness Analysis, By End User
Figure 36: North America Market Attractiveness Analysis, By Country
Figure 37: Latin America spending share, by Solution Type (2022)
Figure 38: Latin America Spending, Snapshot
Figure 39: Latin America Spending (US$ Mn), 2018 to 2022
Figure 40: Latin America Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 41: Latin America Market Attractiveness Analysis, By Solution Type
Figure 42: Latin America Market Attractiveness Analysis, By Deployment
Figure 43: Latin America Market Attractiveness Analysis, By End User
Figure 44: Latin America Market Attractiveness Analysis, By Country
Figure 45: Europe spending share, by Solution Type (2022)
Figure 46: Europe Spending, Snapshot
Figure 47: Europe Spending (US$ Mn), 2018 to 2022
Figure 48: Europe Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 49: Europe Market Attractiveness Analysis, By Solution Type
Figure 50: Europe Market Attractiveness Analysis, By Deployment
Figure 51: Europe Market Attractiveness Analysis, By End User
Figure 52: Europe Market Attractiveness Analysis, By Country
Figure 53: South Asia spending share, by Solution Type (2022)
Figure 54: South Asia Spending, Snapshot
Figure 55: South Asia Spending (US$ Mn), 2018 to 2022
Figure 56: South Asia Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 57: South Asia Market Attractiveness Analysis, By Solution Type
Figure 58: South Asia Market Attractiveness Analysis, By Deployment
Figure 59: South Asia Market Attractiveness Analysis, By End User
Figure 60: South Asia Market Attractiveness Analysis, By Country
Figure 61: East Asia spending share, by Solution Type (2022)
Figure 62: East Asia Spending, Snapshot
Figure 63: East Asia Spending (US$ Mn), 2018 to 2022
Figure 64: East Asia Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 65: East Asia Market Attractiveness Analysis, By Solution Type
Figure 66: East Asia Market Attractiveness Analysis, By Deployment
Figure 67: East Asia Market Attractiveness Analysis, By End User
Figure 68: East Asia Market Attractiveness Analysis, By Country
Figure 69: Oceania spending share, by Solution Type (2022)
Figure 70: Oceania Spending, Snapshot
Figure 71: Oceania Spending (US$ Mn), 2018 to 2022
Figure 72: Oceania Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 73: Oceania Market Attractiveness Analysis, By Solution Type
Figure 74: Oceania Market Attractiveness Analysis, By Deployment
Figure 75: Oceania Market Attractiveness Analysis, By End User
Figure 76: Oceania Market Attractiveness Analysis, By Country
Figure 77: MEA spending share, by Solution Type (2022)
Figure 78: MEA Spending, Snapshot
Figure 79: MEA Spending (US$ Mn), 2018 to 2022
Figure 80: MEA Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 81: MEA Market Attractiveness Analysis, By Solution Type
Figure 82: MEA Market Attractiveness Analysis, By Deployment
Figure 83: MEA Market Attractiveness Analysis, By End User
Figure 84: MEA Market Attractiveness Analysis, By Country
Figure 85: Emerging Countries Spending (US$ Mn), 2018 to 2022
Figure 86: Emerging Countries Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF